References
- Anderson CA, Omar MI, Campbell SE, Hunter KF, Cody JD, Glazener CMA. Conservative management for postprostatectomy urinary incontinence. Cochrane Database Syst Rev. 2015;1:CD001843. doi:https://doi.org/10.1002/14651858.CD001843.pub5.
- Glazener C, Boachie C, Buckley B, et al. Urinary incontinence in men after formal one-to-one pelvic-floor muscle training following radical prostatectomy or transurethral resection of the prostate (MAPS): two parallel randomised controlled trials. Lancet. 2011;378(9788):328–337. doi:https://doi.org/10.1016/S0140-6736(11)60751-4.
- Bauer RM, Gozzi C, Hübner W, et al. Contemporary management of postprostatectomy incontinence. Eur Urol. 2011;59(6):985–996. doi:https://doi.org/10.1016/j.eururo.2011.03.020.
- Comiter C. Surgery for postprostatectomy incontinence: which procedure for which patient? Nat Rev Urol. 2015;12(2):91–99. doi:https://doi.org/10.1038/nrurol.2014.346.
- Balk EM, Rofeberg VN, Adam GP, Kimmel HJ, Trikalinos TA, Jeppson PC. Pharmacologic and nonpharmacologic treatments for urinary incontinence in women: a systematic review and network meta-analysis of clinical outcomes. Ann Intern Med. 2019;170(7):465–479. doi:https://doi.org/10.7326/M18-3227.
- Vaughan CP, Markland AD. Urinary incontinence in women. Ann Intern Med. 2020;172(3):ITC17–ITC32. doi:https://doi.org/10.7326/AITC202002040.
- Crivellaro S, Morlacco A, Bodo G, et al. Systematic review of surgical treatment of post radical prostatectomy stress urinary incontinence. Neurourol Urodyn. 2016;35(8):875–881. doi:https://doi.org/10.1002/nau.22873.
- Aoki Y, Brown HW, Brubaker L, Cornu JN, Daly JO, Cartwright R. Urinary incontinence in women. Nat Rev Dis Primers. 2017;3:17042. doi:https://doi.org/10.1038/nrdp.2017.97.
- Imamura M, Hudson J, Wallace SA, et al. Surgical interventions for women with stress urinary incontinence: systematic review and network meta-analysis of randomised controlled trials. BMJ. 2019;365:l1842. doi:https://doi.org/10.1136/bmj.l1842.
- Cohen AJ, Packiam VT, Nottingham CU, Alberts BD, Faris SF, Bales GT. 30-day morbidity and reoperation following midurethral sling: analysis of 8772 cases using a national prospective database. Urology. 2016;95:72–79. doi:https://doi.org/10.1016/j.urology.2016.04.043.
- Vigil HR, Mallick R, Nitti VW, Lavallée LT, Breau RH, Hickling DR. Risk factors for urinary tract infection following mid urethral sling surgery. J Urol. 2017;197(5):1268–1273. doi:https://doi.org/10.1016/j.juro.2016.12.093.
- Weintraub AY, Reuven Y, Paz-Levy D, et al. Prevalence and risk factors for urinary tract infection up to one year following midurethral sling incontinence surgery. Eur J Obstet Gynecol Reprod Biol. 2018;222:146–150. doi:https://doi.org/10.1016/j.ejogrb.2018.01.028.
- Van der Aa F, Drake MJ, Kasyan GR, Petrolekas A, Cornu J-N, Young Academic Urologists Functional Urology Group. The artificial urinary sphincter after a quarter of a century: a critical systematic review of its use in male non-neurogenic incontinence. Eur Urol. 2013;63(4):681–689. doi:https://doi.org/10.1016/j.eururo.2012.11.034.
- Linder BJ, Piotrowski JT, Ziegelmann MJ, Rivera ME, Rangel LJ, Elliott DS. Perioperative complications following artificial urinary sphincter placement. J Urol. 2015;194(3):716–720. doi:https://doi.org/10.1016/j.juro.2015.02.2945.
- Kirchin V, Page T, Keegan PE, et al. Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev. 2017;7(7):CD003881. doi:https://doi.org/10.1002/14651858.CD003881.pub4.
- Lee PE, Kung RC, Drutz HP. Periurethral autologous fat injection as treatment for female stress urinary incontinence: a randomized double-blind controlled trial. J Urol. 2001;165(1):153–158. doi:https://doi.org/10.1097/00005392-200101000-00037.
- Jankowski RJ, Tu LM, Carlson C, et al. A double-blind, randomized, placebo-controlled clinical trial evaluating the safety and efficacy of autologous muscle derived cells in female subjects with stress urinary incontinence. Int Urol Nephrol. 2018;50(12):2153–2165. doi:https://doi.org/10.1007/s11255-018-2005-8.
- Kontopantelis E, Reeves D. Performance of statistical methods for meta-analysis when true study effects are non-normally distributed: a comparison between DerSimonian-Laird and restricted maximum likelihood. Stat Methods Med Res. 2012;21(6):657–659. doi:https://doi.org/10.1177/0962280211413451.
- Brockwell SE, Gordon IR. A comparison of statistical methods for meta-analysis. Stat Med. 2001;20(6):825–840. doi:https://doi.org/10.1002/sim.650.
- Yiou R, Hogrel J-Y, Loche C-M, et al. Periurethral skeletal myofibre implantation in patients with urinary incontinence and intrinsic sphincter deficiency: a phase I clinical trial. BJU Int. 2013;111(7):1105–1116. doi:https://doi.org/10.1111/j.1464-410X.2012.11682.x.
- Yamamoto T, Gotoh M, Kato M, et al. Periurethral injection of autologous adipose-derived regenerative cells for the treatment of male stress urinary incontinence: Report of three initial cases. Int J Urol. 2012;19(7):652–659. doi:https://doi.org/10.1111/j.1442-2042.2012.02999.x.
- Stangel-Wojcikiewicz K, Jarocha D, Piwowar M, et al. Autologous muscle-derived cells for the treatment of female stress urinary incontinence: a 2-year follow-up of a Polish investigation. Neurourol Urodyn. 2014;33(3):324–330. doi:https://doi.org/10.1002/nau.22404.
- Shirvan MK, Alamdari DH, Mahboub MD, Ghanadi A, Rahimi HR, Seifalian AM. A novel cell therapy for stress urinary incontinence, short-term outcome. Neurourol Urodyn. 2013;32(4):377–382. doi:https://doi.org/10.1002/nau.22301.
- Sharifiaghdas F, Zohrabi F, Moghadasali R, et al. Autologous muscle-derived cell injection for treatment of female stress urinary incontinence: a single- arm clinical trial with 24-months follow-up. Urol J. 2019;16(5):482–487. doi:https://doi.org/10.22037/uj.v0i0.4736.
- Sharifiaghdas F, Tajalli F, Taheri M, et al. Effect of autologous muscle-derived cells in the treatment of urinary incontinence in female patients with intrinsic sphincter deficiency and epispadias: a prospective study. Int J Urol. 2016;23(7):581–586. doi:https://doi.org/10.1111/iju.13097.
- Sèbe P, Doucet C, Cornu JN, et al. Intrasphincteric injections of autologous muscular cells in women with refractory stress urinary incontinence: A prospective study. Int Urogynecol J. 2011;22(2):183–189. doi:https://doi.org/10.1007/s00192-010-1255-5.
- Robert M, Carr L, Herschorn S, Birch C, Murphy M, Kultgen P. Autologous muscle derived cells for treatment of stress urinary incontinence: a single dose study of safety and potential efficacy. Int Urogynecol J. 2013;24 (Suppl 1):S111–S112.
- Peters KM, Dmochowski RR, Carr LK, et al. Autologous muscle derived cells for treatment of stress urinary incontinence in women. J Urol. 2014;192(2):469–476. doi:https://doi.org/10.1016/j.juro.2014.02.047.
- Mitterberger M, Pinggera GM, Marksteiner R, et al. Adult stem cell therapy of female stress urinary incontinence. Eur Urol. 2008;53(1):169–175. doi:https://doi.org/10.1016/j.eururo.2007.07.026.
- Mitterberger M, Marksteiner R, Margreiter E, et al. Myoblast and fibroblast therapy for post-prostatectomy urinary incontinence: 1-year followup of 63 patients. J Urol. 2008;179(1):226–231. doi:https://doi.org/10.1016/j.juro.2007.08.154.
- Mitterberger M, Marksteiner R, Margreiter E, et al. Autologous myoblasts and fibroblasts for female stress incontinence: a 1-year follow-up in 123 patients. BJU Int. 2007;100(5):1081–1085. doi:https://doi.org/10.1111/j.1464-410X.2007.07119.x.
- Lee CN, Jang JB, Kim JY, Koh C, Baek JY, Lee KJ. Human cord blood stem cell therapy for treatment of stress urinary incontinence. J Korean Med Sci. 2010;25(6):813–816. doi:https://doi.org/10.3346/jkms.2010.25.6.813.
- Kuismanen K, Sartoneva R, Haimi S, et al. Autologous adipose stem cells in treatment of female stress urinary incontinence: results of a pilot study. Stem Cells Transl Med. 2014;3(8):936–941. doi:https://doi.org/10.5966/sctm.2013-0197.
- Gräs S, Klarskov N, Lose G. Intraurethral injection of autologous minced skeletal muscle: a simple surgical treatment for stress urinary incontinence. J Urol. 2014;192(3):850–855. doi:https://doi.org/10.1016/j.juro.2014.04.005.
- Gotoh M, Yamamoto T, Shimizu S, et al. Treatment of male stress urinary incontinence using autologous adipose-derived regenerative cells: long-term efficacy and safety. Int J Urol. 2019;26(3):400–405. doi:https://doi.org/10.1111/iju.13886.
- Gotoh M, Yamamoto T, Kato M, et al. Regenerative treatment of male stress urinary incontinence by periurethral injection of autologous adipose-derived regenerative cells: 1-year outcomes in 11 patients. Int J Urol. 2014;21(3):294–300. doi:https://doi.org/10.1111/iju.12266.
- Gerullis H, Eimer C, Georgas E, et al. Muscle-derived cells for treatment of iatrogenic sphincter damage and urinary incontinence in men. Sci World J. 2012;2012:1–6. doi:https://doi.org/10.1100/2012/898535.
- Choi JY, Kim TH, Yang JD, Suh JS, Kwon TG. Adipose-derived regenerative cell injection therapy for postprostatectomy incontinence: a phase I clinical study. Yonsei Med J. 2016;57(5):1152–1158. doi:https://doi.org/10.3349/ymj.2016.57.5.1152.
- Carr LK, Steele D, Steele S, et al. 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(6):881–883. doi:https://doi.org/10.1007/s00192-007-0553-z.
- Carr LK, Robert M, Kultgen PL, et al. Autologous muscle derived cell therapy for stress urinary incontinence: a prospective, dose ranging study. J Urol. 2013;189(2):595–601. doi:https://doi.org/10.1016/j.juro.2012.09.028.
- Blaganje M, Lukanović A. Ultrasound-guided autologous myoblast injections into the extrinsic urethral sphincter: tissue engineering for the treatment of stress urinary incontinence. Obstet Gynecol Surv. 2013;68(2):101–102. doi:https://doi.org/10.1097/OGX.0b013e318280ab32.
- Terrin N, Schmid CH, Lau J. In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias. J Clin Epidemiol. 2005;58(9):894–901. doi:https://doi.org/10.1016/j.jclinepi.2005.01.006.
- Coyne KS, Kvasz M, Ireland AM, Milsom I, Kopp ZS, Chapple CR. Urinary incontinence and its relationship to mental health and health-related quality of life in men and women in Sweden, the United Kingdom, and the United States. Eur Urol. 2012;61(1):88–95. doi:https://doi.org/10.1016/j.eururo.2011.07.049.
- Drake MJ. Managing post-prostatectomy stress urinary incontinence. Lancet. 2011;378(9788):293–294. doi:https://doi.org/10.1016/S0140-6736(11)61034-9.
- Goode PS, Burgio KL, Richter HE, Markland AD. Incontinence in older women. JAMA. 2010;303(21):2172–2181. doi:https://doi.org/10.1001/jama.2010.749.
- Lukacz ES, Santiago-Lastra Y, Albo ME, Brubaker L. Urinary incontinence in women: a review. JAMA. 2017;318(16):1592–1604. doi:https://doi.org/10.1001/jama.2017.12137.
- Wood LN, Anger JT. Urinary incontinence in women. BMJ. 2014;349:g4531. doi:https://doi.org/10.1136/bmj.g4531.
- Kunkle CM, Hallock JL, Hu X, Blomquist J, Thung SF, Werner EF. Cost utility analysis of urethral bulking agents versus midurethral sling in stress urinary incontinence. Female Pelvic Med Reconstr Surg. 2015;21(3):154–159. doi:https://doi.org/10.1097/SPV.0000000000000173.
- Vilsbøll AW, Mouritsen JM, Jensen LP, et al. Cell-based therapy for the treatment of female stress urinary incontinence: an early cost-effectiveness analysis. Regen Med. 2018;13(3):321–330. doi:https://doi.org/10.2217/rme-2017-0124.
- Hillary CJ, Roman S, MacNeil S, Aicher WK, Stenzl A, Chapple CR. Regenerative medicine and injection therapies in stress urinary incontinence. Nat Rev Urol. 2020;17(3):151–161. doi:https://doi.org/10.1038/s41585-019-0273-4.